Jazz Pharmaceuticals
JAZZ
#2126
Rank
A$11.37 B
Marketcap
$188.19
Share price
-2.11%
Change (1 day)
-0.01%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): A$0.44 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$3.90 Billion. In 2023 the company made an earning of A$0.46 Billion, an increase over its 2022 earnings that were of -A$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.44 B-2.64%
2023 A$0.46 B-179.92%
2022 -A$0.58 Billion230.37%
2021 -A$0.18 Billion-141.02%
2020 A$0.42 B-39.45%
2019 A$0.70 B-14.2%
2018 A$0.81 B20.03%
2017 A$0.68 B-17.15%
2016 A$0.82 B22.14%
2015 A$0.67 B187.64%
2014 A$0.23 B-50.79%
2013 A$0.47 B73.63%
2012 A$0.27 B41.69%
2011 A$0.19 B116.61%
2010 A$89.39 M262.77%
2009 A$24.64 M-111.33%
2008 -A$0.22 Billion1.31%
2007 -A$0.22 Billion77.8%
2006 -A$0.13 Billion36.59%
2005 -A$88.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$3.71 Billion-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$3.24 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.69 B 4,181.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$1.27 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel